VANCOUVER, April 11, 2017 /CNW/ - INVICTUS MD
STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC:
IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. ("Acreage
Pharms") which Invictus MD has the option to now acquire 100
percent and expect to exercise in short order, begins their new
cultivation cycle, having received their license to cultivate under
the Access to Cannabis for Medical Purposes Regulations
("ACMPR"), they are firmly committed to patient safety and
the quality of their cannabis.
"Since being founded, we have established and emphasized a
strict culture of regulatory compliance and have committed to
enforcing a rigorous Quality Management Program and closely
monitoring all our suppliers to ensure that any products used meet
or exceed the minimum standards set to comply with Health Canada's
regulations," said Trevor Dixon,
Founder and CEO of Acreage Pharms. "Our best-in-class Quality
Assurance and testing protocols, will give our future clients
additional certainty regarding the purity and safety of the medical
cannabis we produce. When we set out on this exciting new endeavour
we planned on achieving the highest standards when it came to the
cultivation and production of medical cannabis. As part of this, we
made an important investment in our state-of-the-art, purpose built
growth facility near Edson,
Alberta, that enables us to produce medical cannabis that
meets our exacting standards of quality, consistency, and
safety."
Dixon further stated, "additionally, to ensure product integrity
through every step of the growing process, we will utilize
fertilizer from Future Harvest Development Ltd. ("Future Harvest"),
of which Invictus MD currently owns 82.5%, which significantly
reduces the risk of unwanted chemicals that might be found in other
fertilizers." Chris Pearson, Chief
Revenue Officer of Future Harvest commented that, "We're committed
to our customers' quality outcomes. At Future Harvest we're
highly dedicated to consistently producing the highest quality
nutrient formulations. This is achieved through our Standard
Operating Procedures including closely monitoring and having
regular detailed dialogues with our global supply partners to
ensure product consistency, a five times cleaning protocol for all
batch and formulation tanks, and an independent detailed analysis
sample procedure."
"We're very proud that Acreage Pharm's management team has taken
steps to implement quality assurance practices and operational
controls at the very beginning in order to ensure operations are at
a world class standard level," stated Dan Kriznic, Chairman and CEO
of Invictus MD. "We're all steadfast in out commitment to
lead with practices that meet or exceed the regulatory standard for
safety and quality in the Canadian cannabis industry. We are
Canada's Cannabis Company™."
About Invictus MD Strategies Corp.
Invictus MD
Strategies Corp. is focused on three main verticals within the
burgeoning Canadian cannabis sector: Licensed Producers under the
ACMPR including an investment in a fully licensed facility, AB
Laboratories Inc. as well as the option to now acquire 100% of
Acreage Pharms Ltd.; Fertilizer and Nutrients through Future
Harvest Development Ltd.; and Cannabis Data and Delivery, with its
wholly owned subsidiary Poda Technologies Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman & CEO
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
Cautionary Note Regarding Forward-Looking Statements: This
release includes certain statements and information that may
constitute forward-looking information within the meaning of
applicable Canadian securities laws or forward-looking statements
within the meaning of the United States Private Securities
Litigation Reform Act of 1995. All statements in this news release,
other than statements of historical facts, including statements
regarding future estimates, plans, objectives, assumptions or
expectations of future performance, including the timing and
completion of the definitive agreement with Acreage Pharms, the
proposed exercise of the Option and acquisition of Acreage Pharms,
the potential production capacity of the Property are
forward-looking statements and contain forward-looking information.
Generally, forward-looking statements and information can be
identified by the use of forward-looking terminology such as
"intends" or "anticipates", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "should", "would" or "occur". Forward-looking statements
are based on certain material assumptions and analysis made by the
Company and the opinions and estimates of management as of the date
of this press release, including the assumptions that the Company
will be satisfied with its due diligence on Acreage Pharms, that
the Company will obtain stock exchange and all other applicable
regulatory approvals of the proposed Option, that the Company will
raise sufficient funds to exercise the Option, that Acreage Pharms
will abide by and pass all regulations and inspections required
under the ACMPR and be issued a cultivation license and that Health
Canada will approve the required facilities to meet the anticipated
production capacity of the Property. These forward-looking
statements are subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, the risk that the proposed exercise of the
Option may not occur as planned; the timing and receipt of
requisite approvals and failure of the Company to raise sufficient
funds to exercise the Option; Acreage Pharms will not abide by and
pass all regulations and inspections required to be issued a
cultivation license under the ACMPR and Health Canada will not
approve the required facilities to meet the anticipated production
capacity of the Property. Although management of the Company has
attempted to identify important factors that could cause actual
results to differ materially from those contained in
forward-looking statements or forward-looking information, there
may be other factors that cause results not to be as anticipated,
estimated or intended. There can be no assurance that such
statements will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such
statements. Accordingly, readers should not place undue reliance on
forward-looking statements and forward-looking information. Readers
are cautioned that reliance on such information may not be
appropriate for other purposes. The Company does not undertake to
update any forward-looking statement, forward-looking information
or financial out-look that are incorporated by reference herein,
except in accordance with applicable securities laws. We seek safe
harbor.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Invictus MD Strategies